Back to LOVE.TO

Cannara Biotech Inc.

LOVE.TO • Financial Statements

Showing annual data (3 years)

Cannara Biotech Inc. annual financial summary

From company filings. Fiscal years, latest first.

MetricFY2025FY2024FY2023
Revenue$107.3M$81.7M$57.3M
Net income$13.1M$6.4M$6.9M
Operating cash flow$20.0M$10.7M$5.4M
Free cash flow$13.7M$3.2M$-4.4M
Cash & short-term investments$14.4M$6.6M$4.3M
Total debt$41.6M$48.3M$45.8M

Revenue

Revenue

Profitability (Gross Profit, EBITDA, Net Income)

Profitability (Gross Profit, EBITDA, Net Income)

Margins (Gross, EBITDA, Net)

Margins (Gross, EBITDA, Net)

Showing the last 3 fiscal years. Full history, including 32 quarters, is free with an account.

Want the Complete Picture?

Valuation, risk assessment, competitive positioning, and key insights — all in one report.

Free account:3 reports remaining